Literature DB >> 21376672

Temporising versus interventionist management (preterm and at term).

Wessel Ganzevoort1, Baha M Sibai.   

Abstract

Pre-eclampsia has a strong association with adverse outcomes: high incidences at term, and low incidences of morbidity; low incidences remote from term, high incidences of morbidity. The ultimate cure for pre-eclampsia is delivery of the placenta, but gestational age at delivery has an effect on perinatal outcome. We review aspects of two contrasting management approaches, and their indication areas are described (i.e. a more interventionist approach of stabilization (with antihypertensive drugs if needed and corticosteroids for acceleration of fetal lung maturation) and delivery, compared with a more temporizing approach, that treats the symptoms until delivery is necessary. In general, the temporizing approach has been shown to be safe, but beyond 37 weeks gestational age, there is evidence for better outcomes after early delivery. Below that gestational age, trials are awaited that help determine the balance in individual cases, depending on severity of maternal disease and fetal condition.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21376672     DOI: 10.1016/j.bpobgyn.2011.01.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  3 in total

Review 1.  Preventing deaths due to the hypertensive disorders of pregnancy.

Authors:  Peter von Dadelszen; Laura A Magee
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2016-06-28       Impact factor: 5.237

2.  A risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) multi-country prospective cohort study.

Authors:  Beth A Payne; Jennifer A Hutcheon; J Mark Ansermino; David R Hall; Zulfiqar A Bhutta; Shereen Z Bhutta; Christine Biryabarema; William A Grobman; Henk Groen; Farizah Haniff; Jing Li; Laura A Magee; Mario Merialdi; Annettee Nakimuli; Ziguang Qu; Rozina Sikandar; Nelson Sass; Diane Sawchuck; D Wilhelm Steyn; Mariana Widmer; Jian Zhou; Peter von Dadelszen
Journal:  PLoS Med       Date:  2014-01-21       Impact factor: 11.069

3.  Risks of adverse perinatal and maternal outcomes among women with hypertensive disorders of pregnancy in southwestern Uganda.

Authors:  Henry Mark Lugobe; Rose Muhindo; Musa Kayondo; Ian Wilkinson; David Collins Agaba; Carmel McEniery; Samson Okello; Blair J Wylie; Adeline A Boatin
Journal:  PLoS One       Date:  2020-10-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.